Adam is a serial entrepreneur and regenerative medicine executive with deep expertise in business development and company building. He helped scale the first commercial exosome company and several autologous technologies to $50M in global sales in under three years. Previously, he launched a neuromodulation startup that competed directly with Medtronic, Boston Scientific, and Abbott. Adam is skilled at forming high-performance teams and aligning inventors to advance emerging technologies across quantum computing, computational biology, and nanotechnology.

Dmitry Green is an active physicist and has two decades of experience as a partner and managing director in leading hedge funds. He has continued both endeavors side-by-side giving him unique access and perspective on technology and capital markets. Dmitry's contributions to physics are foundational to topological quantum computing and have been recognized as a milestone by the American Physical Society. He is the founder of Ising Ventures, investing in quantum technologies, and serves as a Senior Quantum Advisor to WorldQuant Foundry, a venture lab in NYC. He continues his research as an Adjunct Professor of Physics at Boston University, focusing on superconducting devices.

André is a published author, speaker and expert on DeepTech with 30 years of Fortune 500, investing and startup experience. He is the CEO of Global Quantum Intelligence, the premier market & business intelligence provider in Quantum Tech, and Chairman of OneQuantum, the leading Quantum Tech community globally with 15K+ members. He studied Quantum Computing at MIT (certificates) and holds a MBA in Economics from the University of Chicago Booth School of Business as well as a Masters in Business from ICN School of Management. He speaks English, German, French and poor Italian, has competed in national sailing championships and pursues special forces combat training.